Innova Captab Limited

BSE: 544067 NSE: INNOVACAP
Innova Captab Limited - chemicals in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN L24246MH2005PLC150371 Incorporated 03 January 2005 ROC Mumbai HQ Thane, Maharashtra, India
Active Listed - NSE: INNOVACAP · BSE: 544067 Public Limited Company chemicals
Data last updated
Market Cap
₹6,015 Cr
INNOVACAP · NSE
Share Price
₹1,025.30
-2.45% today
Revenue
₹1,630 Cr
FY 2025-26 · +31.1% YoY
EBITDA
₹243 Cr
Margin 14.9%
Net Profit
₹140 Cr
FY 2025-26 · +9.3% YoY
P/E (TTM)
39.0x
P/B 5.5x
ROE
13.8%
ROCE 14.9%
Debt / Equity
0.33
Interest cover 8.6x

About Innova Captab Limited

Data last updated:

Innova Captab Limited is a public limited company based in Thane, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 03 January 2005 and has been in existence for over 21 years.

Its director Manoj Lohariwala is #1,233 among India's richest people (2026). Its director Vinay Kumar Lohariwala is #1,427 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24246MH2005PLC150371. Its GSTIN is 27AABCH5082R1ZZ (Maharashtra). The company holds 8 GST registrations, of which 6 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 544067 and NSE: INNOVACAP.

The company has an authorised share capital of ₹66 Cr and a paid-up capital of ₹57.22 Cr. It was formerly known as Innova Captab Private Limited and Harun Health Care Private Limited. It is led by directors including Vinay Lohariwala (Managing Director) and Jayant Vasudeo Rao (Whole-Time Director).

Its last annual general meeting (AGM) was held on 31 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Thane, Maharashtra.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹1,630.02 Cr, a growth of 31.1% compared to the previous year. For the same year it recorded a net profit of ₹140.35 Cr (net margin 8.6%) and EBITDA of ₹242.92 Cr (EBITDA margin 14.9%). The net worth stands at ₹1,090.8 Cr (up 13.7% YoY). Total assets are valued at ₹1,446.4 Cr (up 10.6% YoY).

The company has about 1,246 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.

The company is associated with 1 brand: Innova Captab. As per MCA filings, the company has open charges of ₹505.32 Cr and satisfied charges of ₹158.4 Cr on record. Court records list 71 cases involving the company, including 36 filed by the company and 35 filed against it; 13 cases are pending. The company has 14 deals on record (5 secondary share transfers, 4 market trades, 4 funding rounds), with disclosed funding of ₹91.9 Cr; the latest was in January 2024. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Par Formulations Private Limited with revenue of ₹1,462.09 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2024, listing 1,628 overdue payments to 82 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innovacaptab.com.

Company details

CIN L24246MH2005PLC150371
Registration Number 150371
Incorporation Date 03 January 2005
ROC Mumbai
Listing Status Listed - Listed on NSE (INNOVACAP); Listed on BSE (544067)
Company Status Active
Date of Last AGM 31 July 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant

Name history

Innova Captab has undergone 2 name changes throughout its history. The company was previously known as Innova Captab Private Limited, and Harun Health Care Private Limited. The current legal name is Innova Captab Limited.

Company NameStatus
Innova Captab LimitedCurrent
Innova Captab Private LimitedPrevious
Harun Health Care Private LimitedPrevious

CIN history

Innova Captab has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24246MH2005PLC150371, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24246MH2005PLC150371Current
U24246MH2005PTC150371Previous
U24246MH2005PLC150371Previous
Key People
Vinay Lohariwala Managing Director Jayant Vasudeo Rao Whole-Time Director Manoj Kumar Lohariwala Whole-Time Director

Recognitions & Rankings of Innova Captab

Contact details

Innova Captab Limited's registered office is in Thane, Maharashtra. Its website is innovacaptab.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    innovacaptab.com
  • Registered Address
    1513 15th Floor Satra Plaza Chs Ltd., Plot No. 19 & 20 Sector – 19D Vashi Navi Mumbai, Thane, Maharashtra, India – 400703
  • Industry
    Chemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals

To see the full contact details of Innova Captab Limited, buy the company report.

Comprehensive company report
Innova Captab Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Innova Captab operates one associated brand: Innova Captab. Each brand links to its own profile.

BrandDescriptionWebsite
Innova Captab
Pharmaceutical formulations are manufactured by Innova Captab as a CDMO.innovacaptab.com

Business activity

The main business activity of Innova Captab is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Innova Captab Limited, buy the company report.

Financials of Innova Captab Limited

FY 2025-26 filings available

Innova Captab Limited reported revenue of ₹1,630.02 Cr (up 31.1% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹1,630 Cr
+31.1% YoY
EBITDA
₹243 Cr
+30.5% YoY
Profit After Tax
₹140 Cr
+9.3% YoY
Net Worth
₹1,091 Cr
+13.7% YoY
Total Assets
₹1,446 Cr
+10.6% YoY
Total Debt
₹344 Cr
+1.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,6301,2441,081926801411373
Revenue growth+31.1%+15.0%+16.7%+15.7%+94.9%+10.0%-
EBITDA24318615411496.0254.4850.93
EBITDA margin+14.9%+15.0%+14.3%+12.3%+12.0%+13.3%+13.6%
Profit before tax18817113091.7985.7246.3337.52
Net profit14012894.3266.2863.9634.3727.87
Net profit margin+8.6%+10.3%+8.7%+7.2%+8.0%+8.4%+7.5%
EPS (₹)24.6322.4116.4914.16532.94287.50232.38
Balance sheet
Total assets1,4461,3071,085524410192165
Net worth1,091959831323209145110
Total debt34433824519019945.5054.07
Cash & bank3.8768.1786.7518.882.4411.895.18
Net working capital51543634926621694.4592.77
Cash flow
Cash from operations11763.8414667.1258.9041.5730.80
Cash from investing(107)(152)(499)(90.84)(188)(19.67)(6.04)
Cash from financing(21.72)91.5336127.09125(19.34)(23.28)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue471448450380352315316318
Revenue growth (YoY)+33.9%+42.3%+42.3%+19.5%+19.5%---
Other income2.011.561.654.194.483.384.332.22
EBITDA73.1265.0969.3951.8652.1047.6846.5649.73
EBITDA margin+15.5%+14.5%+15.4%+13.6%+14.8%+15.1%+14.7%+15.6%
Depreciation11.7111.3911.4211.3211.059.805.134.99
Interest4.434.593.955.502.861.950.170.15
Profit before tax58.9950.6755.6739.2342.6739.3145.5946.81
Tax14.8612.5913.539.5711.679.7411.3911.81
Net profit44.1338.0842.1429.6631.0029.5734.2035.00
EPS (₹)7.716.657.375.185.425.175.976.12
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,299958865859785411373
Revenue growth+35.6%+10.8%+0.7%+9.3%+91.3%+10.0%-
EBITDA15112210898.5298.5154.4850.93
EBITDA margin+11.7%+12.8%+12.5%+11.5%+12.5%+13.3%+13.6%
Profit before tax11212093.7078.2988.6446.3337.52
Net profit83.6789.5269.5555.8866.1934.3727.87
Net profit margin+6.4%+9.3%+8.0%+6.5%+8.4%+8.4%+7.5%
EPS (₹)14.6315.6311.9111.9955.15287.50232.38
Balance sheet
Total assets1,2151,146970516390192165
Net worth887813724315211145110
Total debt32132924419017645.0354.07
Cash & bank1.9967.8986.3514.992.1911.895.18
Net working capital40032325822016094.3492.77
Cash flow
Cash from operations34.1119.8011239.2858.3441.5730.80
Cash from investing(14.06)(99.75)(472)(87.53)(188)(19.67)(6.04)
Cash from financing(33.99)83.8636851.29125(19.33)(23.28)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue400358364290287243249240
Revenue growth (YoY)+39.6%+47.7%+46.4%+20.7%+26.5%---
Other income2.702.683.214.634.324.363.494.28
Total expenses346320317261252214216207
EBITDA54.0538.6447.0029.3234.8228.1832.5033.18
EBITDA margin+13.5%+10.8%+12.9%+10.1%+12.1%+11.6%+13.1%+13.8%
Depreciation9.689.409.419.489.087.813.083.07
Interest4.033.983.475.212.771.870.130.08
Profit before tax43.0427.9437.3319.2627.2922.8632.7834.31
Tax10.976.789.434.937.005.738.378.71

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 30 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue471448450380352315316318
Revenue growth (YoY)+33.9%+42.3%+42.3%+19.5%+19.5%---
Other income2.011.561.654.194.483.384.332.22
EBITDA73.1265.0969.3951.8652.1047.6846.5649.73
EBITDA margin+15.5%+14.5%+15.4%+13.6%+14.8%+15.1%+14.7%+15.6%
Depreciation11.7111.3911.4211.3211.059.805.134.99
Interest4.434.593.955.502.861.950.170.15
Profit before tax58.9950.6755.6739.2342.6739.3145.5946.81
Tax14.8612.5913.539.5711.679.7411.3911.81
Net profit44.1338.0842.1429.6631.0029.5734.2035.00
EPS (₹)7.716.657.375.185.425.175.976.12
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,6301,2441,081926801411373
Revenue growth+31.1%+15.0%+16.7%+15.7%+94.9%+10.0%-
Other income7.4212.0512.499.202.881.371.30
Total expenses1,3871,058927813705356322
Employee cost16711790.6654.8040.4622.3320.24
EBITDA24318615411496.0254.4850.93
EBITDA margin+14.9%+15.0%+14.3%+12.3%+12.0%+13.3%+13.6%
Depreciation45.1824.7815.9611.087.505.5910.08
Interest16.902.4121.4619.975.683.934.63
Profit before tax18817113091.7985.7246.3337.52
Tax47.3542.7635.1823.8421.7711.859.65
Net profit14012894.3266.2863.9634.3727.87
Net profit margin+8.6%+10.3%+8.7%+7.2%+8.0%+8.4%+7.5%
EPS (₹)24.6322.4116.4914.16532.94287.50232.38
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital57.2357.2357.2394.8512.0012.0012.00
Reserves & surplus1,03490277422919713398.35
Shareholders' funds (net worth)1,091959831323209145110
Minority interest0.000.000.000.000.000.000.00
Secured loans34233524116314937.9442.76
Unsecured loans1.962.944.0527.2650.057.5611.31
Total debt34433824519019945.5054.07
Total liabilities1,4461,3071,085524410192165
Assets
Gross block95690140621620510794.26
Net block84283035818318379.1473.16
Capital work in progress15.5022.5234121.540.037.260.00
Investments41.290.000.000.000.000.000.00
Inventories28320814411712891.4565.49
Sundry debtors43733228826521313986.77
Cash & bank balances3.8768.1786.7518.882.4411.895.18
Loans & advances15787.8860.5041.0635.5428.5713.63
Total current assets882696580442379270171
Total current liabilities36726023117616317678.30
Net working capital51543634926621694.4592.77
Total assets1,4461,3071,085524410192165
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash15.5211.733.530.154.802.240.75
Net cash from operating activities11763.8414667.1258.9041.5730.80
Net cash from investing activities(107)(152)(499)(90.84)(188)(19.67)(6.04)
Net cash from financing activities(21.72)91.5336127.09125(19.34)(23.28)
Net change in cash(12.32)3.798.203.37(4.64)2.561.48
Closing cash3.8768.1786.7518.882.4411.895.18
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+31.1%+15.0%+16.7%+15.7%+94.9%+10.0%-
EBITDA growth+30.5%+20.5%+35.9%+18.4%+76.3%+7.0%-
PBT growth+10.1%+32.0%+41.1%+7.1%+85.0%+23.5%+51.6%
Net income growth+9.3%+36.1%+42.3%+3.6%+86.1%+23.3%-
Revenue CAGR (3Y)+20.7%+15.8%+38.1%+35.4%+31.0%--
EBITDA CAGR (3Y)+28.8%+24.7%+41.5%+30.7%+33.0%--
Profitability & leverage
Net income margin+8.6%+10.3%+8.7%+7.3%+8.0%+8.4%+7.5%
Return on capital employed+14.9%+14.5%+18.8%+23.9%+30.4%+28.2%+26.3%
Return on net worth+13.8%+14.3%+17.0%+28.0%+36.2%+27.0%+28.9%
Debt / equity0.330.330.380.730.690.390.65
Long-term debt / equity0.220.250.260.290.210.070.20
Interest cover8.551.4915.5019.476.428.0411.33
Efficiency & per share
Fixed asset turnover1.761.903.474.395.134.094.06
Inventory turnover6.647.078.287.547.285.237.16
Debtors turnover4.244.013.913.884.563.654.20
EPS (₹)24.6322.4116.4914.16532.94287.50232.38
Dividend per share (₹)2.000.000.000.000.000.000.00
Book value per share (₹)190.61167.66145.2057.611,738.381,206.84919.62
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue400358364290287243249240
Revenue growth (YoY)+39.6%+47.7%+46.4%+20.7%+26.5%---
Other income2.702.683.214.634.324.363.494.28
Total expenses346320317261252214216207
EBITDA54.0538.6447.0029.3234.8228.1832.5033.18
EBITDA margin+13.5%+10.8%+12.9%+10.1%+12.1%+11.6%+13.1%+13.8%
Depreciation9.689.409.419.489.087.813.083.07
Interest4.033.983.475.212.771.870.130.08
Profit before tax43.0427.9437.3319.2627.2922.8632.7834.31
Tax10.976.789.434.937.005.738.378.71
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,299958865859785411373
Revenue growth+35.6%+10.8%+0.7%+9.3%+91.3%+10.0%-
Other income13.2416.7810.728.732.861.371.30
Total expenses1,147836757760687356322
Employee cost11162.7450.1143.6036.3022.2220.24
EBITDA15112210898.5298.5154.4850.93
EBITDA margin+11.7%+12.8%+12.5%+11.5%+12.5%+13.3%+13.6%
Depreciation37.3717.0211.4010.667.405.5910.08
Interest15.422.1713.5918.305.333.934.63
Profit before tax11212093.7078.2988.6446.3337.52
Tax28.1430.4225.5320.7522.4611.859.65
Net profit83.6789.5269.5555.8866.1934.3727.87
Net profit margin+6.4%+9.3%+8.0%+6.5%+8.4%+8.4%+7.5%
EPS (₹)14.6315.6311.9111.9955.15287.50232.38
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital57.2357.2357.2394.8512.0012.0012.00
Reserves & surplus82975666622019913398.35
Shareholders' funds (net worth)887813724315211145110
Secured loans31932624016313937.9442.76
Unsecured loans1.952.913.8627.0736.997.0911.31
Total debt32132924419017645.0354.07
Total liabilities1,2151,146970516390192165
Assets
Gross block74569820819518594.9383.23
Net block64863716416116179.1473.15
Capital work in progress15.2721.0233921.540.037.260.00
Investments10160.0060.0060.0060.000.000.00
Inventories20414093.9997.2710591.4565.49
Sundry debtors33024921723017413986.77
Cash & bank balances1.9967.8986.3514.992.1911.895.18
Loans & advances17272.3739.7036.4531.9528.5713.63
Total current assets709529437378313270171
Total current liabilities30920618015815317678.30
Net working capital40032325822016094.3492.77
Total assets1,2151,146970516390192165
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash15.3111.393.140.104.802.230.75
Net cash from operating activities34.1119.8011239.2858.3441.5730.80
Net cash from investing activities(14.06)(99.75)(472)(87.53)(188)(19.67)(6.04)
Net cash from financing activities(33.99)83.8636851.29125(19.33)(23.28)
Net change in cash(13.94)3.928.253.03(4.69)2.561.48
Closing cash1.9967.8986.3514.992.1911.895.18
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+35.6%+10.8%+0.7%+9.3%+91.3%+10.0%-
EBITDA growth+23.8%+13.3%+9.6%+0.0%+80.8%+7.0%-
PBT growth-6.7%+27.9%+19.7%-11.7%+91.3%+23.5%+9997.0%
Net income growth-6.5%+28.7%+24.5%-15.6%+92.6%+23.3%-
Revenue CAGR (3Y)+14.8%+6.9%+28.2%+32.0%---
EBITDA CAGR (3Y)+15.4%+7.5%+25.6%+24.6%---
Profitability & leverage
Net income margin+6.4%+9.3%+7.9%+6.7%+8.4%+8.4%+7.5%
Return on capital employed+10.8%+11.5%+14.4%+21.3%+32.3%+28.2%+25.5%
Return on net worth+9.9%+11.6%+13.7%+24.0%+37.2%+27.0%+25.3%
Debt / equity0.380.370.420.700.620.390.49
Long-term debt / equity0.270.300.290.300.210.070.11
Interest cover13.532.0614.0720.835.858.0411.33
Efficiency & per share
Fixed asset turnover1.802.114.294.525.614.614.49
Inventory turnover7.558.199.048.487.985.235.70
Debtors turnover4.494.113.874.265.033.654.30
EPS (₹)14.6315.6311.9111.9955.15287.50232.38
Dividend per share (₹)2.000.000.000.000.000.000.00
Book value per share (₹)154.94142.06126.4755.90175.691,206.84919.62

To see the full year-wise statements and ratios of Innova Captab Limited, buy the company report.

Board of directors of Innova Captab Limited

Innova Captab has 8 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jayant Vasudeo Rao
Also directs: Sharon Bio-Medicine Limited
Whole-Time Director22 Nov 20178 Years 11 MonthsCurrent
Shirish Gundopant Belapure
Also directs: Bellapure Onco Phytoceuticals LLP, Jubilant Pharmova Limited, Corona Remedies Limited and 3 more
Director01 Apr 20224 Years 6 MonthsCurrent
Sudhir Kumar Bassi
Also directs: Saatvik Green Energy Limited
Director01 Apr 20224 Years 6 MonthsCurrent
Priyanka Dixit
Also directs: Zuron Fin-Tech Private Limited, Jivfin Ventures Private Limited
Director01 Apr 20224 Years 6 MonthsCurrent
Archit Aggarwal
Also directs: Innoventis Medicare Limited, Archit Infrastructure and Developers LLP, Vga Enterprises LLP and 5 more
Director01 Apr 20224 Years 6 MonthsCurrent
Manoj Kumar Lohariwala
Also directs: Lohariwala Ventures LLP, Regantis Estates LLP, Innoventis Medicare Limited and 2 more
Whole-Time Director03 Jun 200917 Years 4 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer comparison

Innova Captab Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Innova Captab Limitedthis company₹1,630.02 Cr (FY 2026)₹140.35 Cr8.6%31.1%1,246Thane, Maharashtra, India
Par Formulations Private Limited₹1,462.09 Cr (FY 2025)5.0%Chennai, Tamil Nadu, India
Encube Ethicals Private Limited₹1,369 Cr (FY 2025)25.0%Mumbai, Maharashtra, India
Sentiss Pharma Private Limited₹1,262.74 Cr (FY 2025)43.0%New Delhi, Delhi, India
Cipla Health Limited₹1,228.87 Cr (FY 2025)17.0%Mumbai, Maharashtra, India
Neon Laboratories Limited₹1,222.81 Cr (FY 2025)4.0%Mumbai, Maharashtra, India
Corona Remedies Limited₹1,202.35 Cr (FY 2025)18.0%Ahmedabad, Gujarat, India
Hetero Healthcare Limited₹1,189.8 Cr (FY 2025)16.0%Hyderabad, Telangana, India
BDR Pharmaceuticals International Private Limited₹1,137.31 Cr (FY 2025)2.0%Mumbai, Maharashtra, India

To see the full peer comparison of Innova Captab Limited, buy the company report.

Auditor

Innova Captab Limited is audited by B S R AND Co. LLP for the financial year 2025.

Auditor firmFinancial yearFirm registration number
B S R AND Co. LLPFY 2025101248W/ W-100022

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 50.90%, foreign institutional investors hold 0.30%, domestic institutional investors hold 20.00% and retail and other public shareholders hold 28.80%.

Promoters: 50.90%DII (Domestic Institutional): 20.00%FII (Foreign Institutional): 0.30%Retail & Others: 28.80%
Sep 2026
QUARTER
50.90% Promoters
20.00% DII (Domestic Institutional)
0.30% FII (Foreign Institutional)
28.80% Retail & Others
Promoter holding - history
Now 50.90% · Sep 2026High 50.90% · Dec 2025Low 50.90% · Dec 2025
49%49.8%50.5%51.3%52%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 50.90%Mar 2026: 50.90%Jun 2026: 50.90%Sep 2026: 50.90%50.90%50.90%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters50.90%50.90%50.90%50.90%
Public49.10%49.10%49.10%49.10%

Charges & borrowings

Open charges
₹505.32 Cr
Satisfied charges
₹158.4 Cr
Breakdown by lending institutions
State Bank of India₹235.00 Cr
Hdfc Bank Limited₹222.32 Cr
Yes Bank Limited₹48.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Jul 2025101135336Hdfc Bank Limited₹52.32 CrOpen
29 Sep 2022100621143Hdfc Bank Limited₹150 CrOpen
29 Sep 2022100621145Hdfc Bank Limited₹20 CrOpen
31 Aug 2017100123200Yes Bank Limited₹48 CrOpen
01 Nov 201110320494State Bank of India₹235 CrOpen

To see the full charge records of Innova Captab Limited, buy the company report.

Total charge records: 17 View all charges

Deals & funding

Innova Captab Limited has 14 deals on record (5 secondary share transfers, 4 market trades, 4 funding rounds), with disclosed funding of ₹91.9 Cr; the latest was in January 2024.

Total deals
14
Secondary share transfers
5
Market trades
4
Funding rounds
4
IPO
1
Disclosed funding
₹91.9 Cr

Deals on record (5 of 14)

WhenDealAmountParties
Jan 2024Market trade₹19.58 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP
Jan 2024Market trade₹25.1 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP
Dec 2023Market trade₹19.3 CrBuyer: Mansi Share and Stock Broking Private Limited
Seller: Mansi Share and Stock Broking Private Limited
Dec 2023Market trade₹179.08 CrBuyer: Mansi Share And Stock Advisors Pvt Ltd, Canara Robeco Mutual Fund, Invesco Mutual Fund
Seller: Mansi Share And Stock Advisors Pvt Ltd, Musigma Securities, Goldmine Stocks Pvt Ltd
Dec 2023IPO₹570 CrInvestors: IPO Shareholders - Innova Captab Limited, Sbi Life Insurance Ltd, 360 ONE (IIFL Asset Management)
Seller: 3 individuals

To see the full deal history of Innova Captab Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Innova Captab Limited was last rated by Care on 17 Apr 2026.

Rating agencyRated onRating
Care17 Apr 2026

To see the full credit ratings and regulatory alerts of Innova Captab Limited, buy the company report.

MSME payment delays

Innova Captab Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 1,628 overdue payments to 82 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 82)

SupplierAmount dueDue sinceReported on
Shreenath Chemicals
Shako Plastick
Mehta Vet Chem
Micromeg Enterprises Private Limited
Jayanti Polymer

To see the full MSME payment records of Innova Captab Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Innova Captab has 2 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

2
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Sharon Bio Medicine LimitedU24110MH1989PLC052251
Univentis Medicare LimitedU24232MH2015PLC402722

To see the full group structure of Innova Captab Limited, buy the company report.

Employees & EPFO

Innova Captab Limited has a workforce of 1,246 employees on its EPFO records as of Jan 09, 2026, across 2 active EPFO establishments.

Employee count
1,246
Active EPFO establishments
2
Employee growth
-1.74%

GST

Innova Captab has 8 GST registrations: 6 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
8
Active
6
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AABCH5082R1ZZMaharashtraActive25 Oct 2023
02AABCH5082R2ZAHimachal PradeshActive01 Jul 2017
01AABCH5082R1ZDJammu and KashmirActive24 Mar 2022
06AABCH5082R1Z3HaryanaActive01 Jul 2022

To see the full GST registrations and return filing status of Innova Captab Limited, buy the company report.

Recent activity

Innova Captab Limited has 26 board changes on record since 2009: 8 appointments and 18 cessations. The latest: Gaurav Srivastava ceased to be CFO on 29 Mar 2024.

Filing
Innova Captab Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai Ii.
Charges
A charge with State Bank Of India of Rs. 235.00 Cr registered on 01 Nov 2011 with Charge ID 10320494 was modified on 07 Feb 2026.
Charges
A charge with Yes Bank Limited of Rs. 48.00 Cr registered on 31 Aug 2017 with Charge ID 100123200 was modified on 16 Dec 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 150.00 Cr registered on 29 Sep 2022 with Charge ID 100621143 was modified on 04 Oct 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 52.32 Cr registered on 28 Jul 2025 with Charge ID 101135336 was modified on 02 Sep 2025.
AGM
Innova Captab Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 52.32 Cr with Charge ID 101135336 was registered on 28 Jul 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 20.00 Cr registered on 29 Sep 2022 with Charge ID 100621145 was modified on 19 Dec 2024.
Charges
A charge registered on 17 Sep 2020 via Charge ID 100382802 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 22 May 2024.
Charges
A charge registered on 14 Sep 2020 via Charge ID 100383838 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 22 May 2024.
Ceased
Gaurav Srivastava ceased to be CFO.
Ceased
Rishi Gupta ceased to be CFO.

54 earlier events are in the company report.

News

INNOVACAP: RS. 194.40 CRORES BSE BLOCK TRADE; FOR ~ 1,800,000 SHARES, AT RS. 1080.00
30 Sep 2026 · Exchange Update

Frequently asked questions

Innova Captab is an active public limited company based in Thane, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 03 January 2005 (21+ years old) and is registered under CIN L24246MH2005PLC150371. Listed on BSE: 544067 and NSE: INNOVACAP.

Innova Captab reported revenue of ₹1,630.02 Cr for FY 2025-26 (up 31.1% YoY) based on consolidated financials.

Innova Captab has 8 current directors:

The latest financial statements of Innova Captab on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 31 July 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Innova Captab is 27AABCH5082R1ZZ, registered in Maharashtra. The company has 8 GST registrations in all, of which 6 are active and 2 are cancelled or inactive. Other active GSTINs include 02AABCH5082R2ZA (Himachal Pradesh), 01AABCH5082R1ZD (Jammu and Kashmir), 06AABCH5082R1Z3 (Haryana).

The CIN (Corporate Identification Number) of Innova Captab is L24246MH2005PLC150371. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Innova Captab is a listed company as per MCA records. Its shares are listed on both BSE (code: 544067) and NSE (symbol: INNOVACAP).

Innova Captab has 71 court cases on record: 36 filed by the company and 35 filed against it. 13 are pending. Most are in the district courts.

Innova Captab was incorporated on 03 January 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.

Innova Captab has 14 deals on record (5 secondary share transfers, 4 market trades, 4 funding rounds), with disclosed funding of ₹91.9 Cr; the latest was in January 2024.

The peers of Innova Captab by revenue are Par Formulations Private Limited, Encube Ethicals Private Limited, Sentiss Pharma Private Limited, Cipla Health Limited, Neon Laboratories Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Gaurav Srivastava ceased to be CFO on 29 Mar 2024. Rishi Gupta ceased to be CFO on 26 Apr 2023. Archit Aggarwal ceased to be Additional Director on 04 Apr 2022. Innova Captab has 26 board changes on record in total.